1. Rural and urban differentials in primary care management of chronic heart failure: new data from the CASE study.
- Author
-
Clark RA, Eckert KA, Stewart S, Phillips SM, Yallop JJ, Tonkin AM, and Krum H
- Subjects
- Angiotensin-Converting Enzyme Inhibitors therapeutic use, Australia epidemiology, Cross-Sectional Studies, Drug Utilization statistics & numerical data, Echocardiography statistics & numerical data, Evidence-Based Medicine, Health Care Surveys, Heart Failure diagnosis, Heart Failure epidemiology, Hospitalization statistics & numerical data, Humans, Referral and Consultation statistics & numerical data, Rural Population, Urban Population, Heart Failure therapy, Practice Patterns, Physicians' statistics & numerical data, Primary Health Care, Rural Health Services statistics & numerical data, Urban Health Services statistics & numerical data
- Abstract
Objective: To determine whether primary care management of chronic heart failure (CHF) differed between rural and urban areas in Australia., Design: A cross-sectional survey stratified by Rural, Remote and Metropolitan Areas (RRMA) classification. The primary source of data was the Cardiac Awareness Survey and Evaluation (CASE) study., Setting: Secondary analysis of data obtained from 341 Australian general practitioners and 23 845 adults aged 60 years or more in 1998., Main Outcome Measures: CHF determined by criteria recommended by the World Health Organization, diagnostic practices, use of pharmacotherapy, and CHF-related hospital admissions in the 12 months before the study., Results: There was a significantly higher prevalence of CHF among general practice patients in large and small rural towns (16.1%) compared with capital city and metropolitan areas (12.4%) (P < 0.001). Echocardiography was used less often for diagnosis in rural towns compared with metropolitan areas (52.0% v 67.3%, P < 0.001). Rates of specialist referral were also significantly lower in rural towns than in metropolitan areas (59.1% v 69.6%, P < 0.001), as were prescribing rates of angiotensin-converting enzyme inhibitors (51.4% v 60.1%, P < 0.001). There was no geographical variation in prescribing rates of beta-blockers (12.6% [rural] v 11.8% [metropolitan], P = 0.32). Overall, few survey participants received recommended "evidence-based practice" diagnosis and management for CHF (metropolitan, 4.6%; rural, 3.9%; and remote areas, 3.7%)., Conclusions: This study found a higher prevalence of CHF, and significantly lower use of recommended diagnostic methods and pharmacological treatment among patients in rural areas.
- Published
- 2007
- Full Text
- View/download PDF